Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ex vivo potency of edoxaban in patients with cirrhosis
NL-OMON45987Phase 3Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of edoxaban in Cirrhosis and hepatic disease (2 arms), sponsored by University Medical Center Groningen. Started Dec 2016; status: active, not recruiting.
02
Drugs
edoxaban
03
Conditions
Cirrhosishepatic disease
Beyond the preview
Go deeper on NL-OMON45987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45987.